Novel Functionalized Pyrrolopyridines to Target Brk

Area of Science:

• Medicinal Chemistry
• Oncology
• Drug Discovery

Background:

• Cancer therapies face increasing resistance to protein kinase inhibitors.
• Brk tyrosine kinase is a novel target implicated in breast cancer progression and poor patient outcomes.
• No effective Brk inhibitors have been identified previously.

Purpose of the Study:

• To discover and develop novel small-molecule inhibitors targeting Brk.
• To explore pyrrolopyridine derivatives as potential Brk inhibitors.
• To evaluate the inhibitory activity against Brk and HER2 kinases.

Main Methods:

• Synthesis of novel functionalized pyrrolopyridines via one- and two-step reactions.
• Modification of the molecular scaffold and 4-aniline residue.
• Enzyme inhibition assays using radiolabeled Brk and HER2.

Main Results:

• Specific substituents on pyrrolopyridines enhanced Brk inhibitory activity.
• 3-hydroxy and bromo/nitro substituents on aniline residues were most effective for Brk inhibition.
• The synthesized compounds also demonstrated significant HER2 inhibitory activity.

Conclusions:

• Novel pyrrolopyridines represent a promising class of nanomolar Brk inhibitors.
• These compounds exhibit dual inhibitory activity against Brk and HER2.
• This discovery provides the first class of Brk inhibitors for potential anticancer therapies.